Advanced Search
Article Contents
ABOUT THIS ARTICLE
The Innovation Medicine > 2025 Vol. 3 > No. 4 > 100170
Next Article Previous Article
NEWS & BUZZ   Open Access     Cite

Organ regeneration and fibrosis sub-forum advances global solutions for fibrotic diseases

  • 1.

    The Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University, Chengdu 610041, China

  • 2.

    Department of Respiratory and Critical Care Medicine, Xiangya Hospital, Central South University, Changsha 410008, China

  • 3.

    Department of Urology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210003, China

  • 4.

    Suining Central Hospital, Suining 629099, China

  • 5.

    Department of Physiology, Xiangya School of Basic Medical Science, Central South University, Changsha 410008, China

  • 6.

    School of Laboratory Medicine/Clinical IVD Joint Research Center of Chengdu Medical College-Maccura Biotechnology, Chengdu Medical College, Chengdu 610500, China

    • Show all affliationsShow less
More Information
The Innovation Medicine  3(4),  https://doi.org/10.59717/j.xinn-med.2025.100170  |  Cite this article
    • FullText(HTML)
  • 加载中
    • REFERENCES
  • [1] Mutsaers H.A.M., Merrild C., Nørregaard R., et al. (2023). The impact of fibrotic diseases on global mortality from 1990 to 2019. J. Transl. Med. 21:818. DOI:10.1186/s12967-023-04690-7

    View in Article CrossRef Google Scholar

    [2] Hysi E., Baek J., Koven A., et al. (2025). A first-in-human study of quantitative ultrasound to assess transplant kidney fibrosis. Nat. Med. 31:970−978. DOI:10.1038/s41591-024-03417-5

    View in Article CrossRef Google Scholar

    [3] Zhou A., Lang Q., Zhao C., et al. (2025). Nerandomilast shatters decade-long stalemate in fibrotic lung diseases: FDA fast track insights. Innov. Med. 3:100151. DOI:10.59717/j.xinn-med.2025.100151

    View in Article CrossRef Google Scholar

    [4] Han M.M., He X.Y., Tang L., et al. (2023). Nanoengineered mesenchymal stem cell therapy for pulmonary fibrosis in young and aged mice. Sci. Adv. 9:eadg5358. DOI:10.1126/sciadv.adg5358

    View in Article CrossRef Google Scholar

    [5] Gompelmann D., Gysan M.R., Desbordes P., et al. (2025). AI-powered evaluation of lung function for diagnosis of interstitial lung disease. Thorax 80:445−450. DOI:10.1136/thorax-2024-221537

    View in Article CrossRef Google Scholar

    • Cited by

  • Cite this article:

    Mo C., Zhou A., Wang Z., et al. (2025). Organ regeneration and fibrosis sub-forum advances global solutions for fibrotic diseases. The Innovation Medicine 3:100170. https://doi.org/10.59717/j.xinn-med.2025.100170
    Mo C., Zhou A., Wang Z., et al. (2025). Organ regeneration and fibrosis sub-forum advances global solutions for fibrotic diseases. The Innovation Medicine 3:100170. https://doi.org/10.59717/j.xinn-med.2025.100170

Welcome!

To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.

PDF
Figures(1)    

Share

  • Share the QR code with wechat scanning code to friends and circle of friends.

Article Metrics

Article views(1398) PDF downloads(833)

Relative Articles

Cited by

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return

    {{newsColumn.name}}

    {{newsColumn.name}}

    Stay connected

    {{newsColumn.name}}

    Website copyright © Innovation Press. Published articles are licensed under CC BY with copyright retained by the authors.